Genetic keys to COVID-19 vaccine response unlocked

A genome-wide association study in the U.K. Biobank reveals genetic factors influencing IgG serostatus against SARS-CoV-2, highlighting the role of HLA class II genes in variable immune responses to COVID-19 vaccines.

Astellas taps Poseida for second CAR-T deal focused on solid tumors

Astellas Pharma is signing Poseida Therapeutics to a second deal focused on developing off-the-shelf solid tumor cell therapies after the companies first teamed up in

May 2, 2024

Groundbreaking protein atlas reveals cellular insights for disease research

Scientists at the University of Cambridge have developed an atlas of proteins describing how they behave inside human cells.

July 10, 2024

Biotech’s most interesting fundraisings from the last week

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi, biotech friends. As

May 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.